Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts

gan Henkle, Emily, Winthrop, Kevin
Cyhoeddwyd yn Clin Chest Med (2014)

To immunosuppress: whom, when and how? That is the question with COVID-19

gan Winthrop, Kevin L, Mariette, Xavier
Cyhoeddwyd yn Ann Rheum Dis (2020)

Rheumatology and COVID-19 at 1 year: facing the unknowns

gan Calabrese, Leonard, Winthrop, Kevin L
Cyhoeddwyd yn Ann Rheum Dis (2021)

Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management

gan Daley, Charles L, Winthrop, Kevin L
Cyhoeddwyd yn J Infect Dis (2020)

COVID-19 vaccination and antirheumatic therapy

gan Arnold, Jack, Winthrop, Kevin, Emery, Paul
Cyhoeddwyd yn Rheumatology (Oxford) (2021)

Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)

gan Varley, Cara D., Winthrop, Kevin L.
Cyhoeddwyd yn Curr Rheumatol Rep (2021)

The Challenge of Pulmonary Nontuberculous Mycobacterial Infection

gan Novosad, Shannon, Henkle, Emily, Winthrop, Kevin L.
Cyhoeddwyd yn Curr Pulmonol Rep (2015)

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data

gan Simon, Teresa A., Dong, Lixian, Winthrop, Kevin L.
Cyhoeddwyd yn Arthritis Res Ther (2021)

Vaccinations for Rheumatoid Arthritis

gan Perry, Lisa M., Winthrop, Kevin L., Curtis, Jeffrey R.
Cyhoeddwyd 2014

COVID-19 pandemic management and the rheumatology patient

gan Varley, Cara D., Ku, Jennifer H., Winthrop, Kevin L.
Cyhoeddwyd yn Best Pract Res Clin Rheumatol (2021)

Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007–2012

gan Henkle, Emily, Hedberg, Katrina, Schafer, Sean D., Winthrop, Kevin L.
Cyhoeddwyd yn Emerg Infect Dis (2017)

Training of an ophthalmologist in concepts and practice of community eye health

gan Furtado, João M, Lansingh, Van C, Winthrop, Kevin L, Spivey, Bruce
Cyhoeddwyd 2012

Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012

gan Henkle, Emily, Hedberg, Katrina, Schafer, Sean, Novosad, Shannon, Winthrop, Kevin L.
Cyhoeddwyd yn Ann Am Thorac Soc (2015)

The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to...

gan Wan, Marilyn T., Shin, Daniel B., Winthrop, Kevin L., Gelfand, Joel M.
Cyhoeddwyd yn J Am Acad Dermatol (2020)

Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”

gan Wan, Marilyn T., Shin, Daniel B., Winthrop, Kevin L., Gelfand, Joel M.
Cyhoeddwyd yn J Am Acad Dermatol (2020)

In response to: “Reply to research letter”

gan Wan, Marilyn T., Shin, Daniel B., Winthrop, Kevin L., Gelfand, Joel M.
Cyhoeddwyd yn J Am Acad Dermatol (2020)

Opinions Differ by Expertise in Mycobacterium avium Complex Disease

gan Marras, Theodore K., Prevots, D. Rebecca, Jamieson, Frances B., Winthrop, Kevin L.
Cyhoeddwyd 2014

Ocular toxoplasmosis II: clinical features, pathology and management

gan Butler, Nicholas J, Furtado, João M, Winthrop, Kevin L, Smith, Justine R
Cyhoeddwyd 2012

Real-World Comparative Risks of Herpes Virus Infections in Tofacitinib and Biologic-Treated Rheumatoid Arthritis Patients

gan Curtis, Jeffrey R, Xie, Fenglong, Yun, Huifeng, Bernatsky, Sasha, Winthrop, Kevin L.
Cyhoeddwyd yn Ann Rheum Dis (2016)

Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

gan Costello, Ruth E, Humphreys, Jenny H, Winthrop, Kevin L, Dixon, William G
Cyhoeddwyd yn Ann Rheum Dis (2020)